Affiliation: Karolinska Institutet
- Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairmentChristin Andersson
Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Dement Geriatr Cogn Disord 23:87-95. 2007..To investigate the relationships between episodic memory, APOE genotype, CSF markers (total tau, T-tau; phospho-tau, P-tau; beta-amyloid, Abeta42) and longitudinal cognitive decline...
- Increasing CSF phospho-tau levels during cognitive decline and progression to dementiaChristin Andersson
Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, NOVUM Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
Neurobiol Aging 29:1466-73. 2008..Little is known about longitudinal changes of cerebrospinal fluid (CSF) biomarkers during cognitive decline in neurodegenerative disease progression...
- Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatientsChristin Andersson
Neurotec Department, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Dement Geriatr Cogn Disord 21:251-9. 2006..To investigate whether application of cutoff levels in an episodic memory test (Rey Auditory Verbal Learning Test, RAVLT) is a useful method for identifying patients at high and low risk of cognitive decline and subsequent dementia...